AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2017
Mar 31, 2017
30826_dirs_2017-03-31_33f28605-96a9-41b6-9b02-da841ebb3e6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2017-03-29
Reporting Person: RYAN THOMAS F JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-29 | Common Stock | G | 750 | $0.00 | Disposed | 7844 | Direct |
| 2017-03-29 | Common Stock | G | 350 | $0.00 | Disposed | 7494 | Direct |
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23